Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control Study

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) constitutes a devastating disease with late diagnosis and poor overall survival, complicated by clinical presentations similar to benign pancreatic diseases. We aimed to analyse clinical parameters for differentiating suspected PDAC from benign...

Descripción completa

Detalles Bibliográficos
Autores principales: Zardab, Mohamed, Balarajah, Vickna, Banerjee, Abhirup, Stasinos, Konstantinos, Saad, Amina, Imrali, Ahmet, Hughes, Christine, Roberts, Rhiannon, Vajrala, Ajith, Chelala, Claude, Kocher, Hemant M., Dayem Ullah, Abu Z. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818842/
https://www.ncbi.nlm.nih.gov/pubmed/36612275
http://dx.doi.org/10.3390/cancers15010280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818842/
https://www.ncbi.nlm.nih.gov/pubmed/36612275
http://dx.doi.org/10.3390/cancers15010280

Ejemplares similares